Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: 7:59:59 p.m. EST ...
After hours: 7 February at 7:59:59 pm GMT-5 ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
After hours: February 7 at 7:58:23 p.m. EST ...
After hours: 7:58:23 pm GMT-5 ...
After hours: 7 February at 7:58:23 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback